Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.
about
Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part IMycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.Sensitive and validated LC-MS/MS methods to evaluate mycophenolic acid pharmacokinetics and pharmacodynamics in hematopoietic stem cell transplant patients.Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil.Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patientsImmunosuppressant drug monitoring: is the laboratory meeting clinical expectations?Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.Drug choices in autoimmune hepatitis: part B--Nonsteroids.Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in Chinese adult renal transplant recipients.Correlation between pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients.Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.Usefulness of limited sampling strategy for mycophenolic acid area under the curve considering postoperative days in living-donor renal transplant recipients with concomitant prolonged-release tacrolimus.Mycophenolate pharmacokinetics in early period following lung or heart transplantation.Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection.Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients.Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients.
P2860
Q34152549-C9E05153-AFE8-4816-8637-DA296E04289EQ34610933-FD742A08-B854-439F-B2B4-69FFB975DF5DQ35129548-536FC61E-2EBB-4FF0-9FAC-2A9542815171Q35549667-B3FEED67-17AF-47B0-B36C-FDF00654DCBDQ35825497-42FA886E-B787-408E-9065-B4F545EC58A6Q35827831-262D52F4-F37B-47A6-BE41-24BC5D3FD02EQ35980234-CA5BDDBB-3088-4EAB-90E1-BBE02B9E20CAQ36379888-38C72D6E-52C1-47B1-A973-6D1B0DE70A01Q36544981-90AFB2CB-8B95-4D7E-B247-4C7364373CB9Q37824708-6C5A7BEC-E645-4C15-8D74-4B513407A327Q38051706-3E67CEAE-BA77-49AE-B5CD-EA8D86612313Q38610665-F4213DDB-2500-4DD7-BFFC-C79BCBD0ED24Q39729251-9E00C6DC-34A1-4D15-9446-9D54CF5FE685Q40485525-67676C47-9FB0-448F-B304-A9B8FAB4C3DBQ41051341-CF63D0EC-D48A-4F30-8629-2C02FD9F38E2Q42613833-B32334B7-8FD8-4734-A207-0DB01AA18D0FQ43993075-22931D87-5F04-4E52-8B5A-B17D1856CAB6Q46140802-C4C70EBD-2D13-4849-89C2-7BF816076C19Q46942520-71AE8B55-FAAE-4A81-BC24-C27336AE2430Q53163992-E7E808FD-6039-4638-86B0-B898C1C7CC43
P2860
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetic, pharmacodynam ...... and heart transplant patients.
@ast
Pharmacokinetic, pharmacodynam ...... and heart transplant patients.
@en
type
label
Pharmacokinetic, pharmacodynam ...... and heart transplant patients.
@ast
Pharmacokinetic, pharmacodynam ...... and heart transplant patients.
@en
prefLabel
Pharmacokinetic, pharmacodynam ...... and heart transplant patients.
@ast
Pharmacokinetic, pharmacodynam ...... and heart transplant patients.
@en
P2093
P1476
Pharmacokinetic, pharmacodynam ...... and heart transplant patients.
@en
P2093
P356
10.1016/S0009-9120(00)00184-3
P577
2001-02-01T00:00:00Z